This page shows the latest leukaemia combo therapy news and features for those working in and with pharma, biotech and healthcare.
Imbruvica paired with Roche’s Gazyva for previously untreated CLL patients. The pairing of of AbbVie’s Imbruvica and Roche’s Gazyva has hit the mark in a chronic lymphocytic leukaemia ... or more) with either CLL or small lymphocytic leukaemia (SLL)
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
We’re a specialist health consultancy that supports companies, healthcare professionals and patients to work hand in hand with a common...